Intra-Cellular Therapies, Inc. Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Intra-Cellular Therapies, Inc. for January 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 1.50 | 12,500 | 18,750 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 1.50 | 12,500 | 18,750 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 2.74 | 12,500 | 34,250 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 2.74 | 12,500 | 34,250 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 2.84 | 12,500 | 35,500 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 3.26 | 12,500 | 40,750 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 3.26 | 20,000 | 65,200 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 95,000 | 0 | 110,742 | 15.7 K to 110.7 K (+603.48 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 95,000 | 0 | 21,671 | 116.7 K to 21.7 K (-81.43 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 1.50 | 12,500 | 18,750 | 116,671 | 104.2 K to 116.7 K (+12.00 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 1.50 | 12,500 | 18,750 | 104,171 | 91.7 K to 104.2 K (+13.64 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 2.74 | 12,500 | 34,250 | 91,671 | 79.2 K to 91.7 K (+15.79 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 2.74 | 12,500 | 34,250 | 79,171 | 66.7 K to 79.2 K (+18.75 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 2.84 | 12,500 | 35,500 | 66,671 | 54.2 K to 66.7 K (+23.08 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 3.26 | 12,500 | 40,750 | 54,171 | 41.7 K to 54.2 K (+30.00 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 3.26 | 20,000 | 65,200 | 41,671 | 21.7 K to 41.7 K (+92.29 %) |
| Jan 09 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 16.59 | 800 | 13,272 | 10,128 | 10.9 K to 10.1 K (-7.32 %) |
| Jan 09 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 16.55 | 4,081 | 67,541 | 1,088,707 | 1.1 M to 1.1 M (-0.37 %) |
| Jan 09 2017 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 16.58 | 1,918 | 31,800 | 63,389 | 65.3 K to 63.4 K (-2.94 %) |
| Jan 09 2017 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Sell | S | 16.55 | 1,601 | 26,497 | 21,506 | 23.1 K to 21.5 K (-6.93 %) |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 0.00 | 1,553 | 0 | 3,108 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | A | 0.00 | 7,946 | 0 | 7,946 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | A | 15.73 | 31,858 | 501,126 | 31,858 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 0.00 | 1,553 | 0 | 10,928 | 9.4 K to 10.9 K (+16.57 %) |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 6,603 | 0 | 13,208 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 0.00 | 33,773 | 0 | 33,773 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 15.73 | 135,399 | 2,129,826 | 135,399 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 6,603 | 0 | 1,092,788 | 1.1 M to 1.1 M (+0.61 %) |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 0.00 | 3,107 | 0 | 6,216 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | A | 0.00 | 15,893 | 0 | 15,893 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | A | 15.73 | 63,717 | 1,002,268 | 63,717 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 0.00 | 3,107 | 0 | 65,307 | 62.2 K to 65.3 K (+5.00 %) |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | M | 0.00 | 3,107 | 0 | 6,216 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | A | 0.00 | 15,893 | 0 | 15,893 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | A | 15.73 | 63,717 | 1,002,268 | 63,717 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Buy | M | 0.00 | 3,107 | 0 | 23,107 | 20 K to 23.1 K (+15.54 %) |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 7,946 | 0 | 7,946 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 15.73 | 31,858 | 501,126 | 31,858 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 1,757 | 0 | 3,515 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Buy | M | 0.00 | 1,757 | 0 | 26,757 | 25 K to 26.8 K (+7.03 %) |
| Jan 03 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 994 | 0 | 21,671 | 20.7 K to 21.7 K (+4.81 %) |
| Jan 03 2017 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 0.00 | 331 | 0 | 2,286 | 2 K to 2.3 K (+16.93 %) |
| Jan 03 2017 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 960 | 0 | 32,630 | 31.7 K to 32.6 K (+3.03 %) |
| Jan 03 2017 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 911 | 0 | 5,797 | 4.9 K to 5.8 K (+18.65 %) |
| Jan 03 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 960 | 0 | 731,489 | 730.5 K to 731.5 K (+0.13 %) |